- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Lennox-Gastaut syndrome
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 449KB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 67KB)
Cannabidiol – July 2022
Cannabidiol: Oral liquid 100 mg per mL, 100 mL; Epidyolex®
Last updated
28 October 2022